每經AI快訊，7月(yue)16日(ri)，諾輝健康發布(bu)公(gong)(gong)告，公(gong)(gong)司董(dong)事會(hui)謹此(ci)宣布(bu)，其有意根據公(gong)(gong)司股(gu)東于2023年6月(yue)9日(ri)舉(ju)行(xing)的(de)公(gong)(gong)司股(gu)東周(zhou)年大(da)會(hui)上(shang)通過的(de)決議案行(xing)使授予(yu)董(dong)事會(hui)的(de)一般授權(quan)項下的(de)權(quan)力，購回最多4575.92萬(wan)股(gu)公(gong)(gong)司股(gu)份，即于股(gu)東周(zhou)年大(da)會(hui)當日(ri)已發行(xing)股(gu)份總(zong)數的(de)10%。